TELUS Digital · 3 weeks ago
On Site Research Study
TELUS Digital is looking for Ph.D. experts in biology to join their AI Community. The role involves participating in a research study to explore biology-related capabilities in AI tools, requiring interaction with an AI chatbot over a total of six hours.
AnalyticsArtificial Intelligence (AI)ConsultingData Collection and LabelingInformation ServicesInformation TechnologyOutsourcing
Responsibilities
Help us probe the frontiers of these tools
Interact with a new AI chatbot during the research study
Qualification
Required
18+ years of age
English proficiency
U.S. citizens or U.S. permanent residents with a valid permanent resident card or US registered refugees (student visas are not eligible)
Be able to commute to the specified on-site location
Attained Ph.D. in the field of biology in genetics, virology, and/or microbiology (will need to prove with an attached Ph.D. degree certificate)
At least one year of hands-on professional experience in the wet lab (e.g. pipetting, growing cell cultures, running gels, etc - activities at a wet lab bench)
At least 1 year of biosecurity experience (i.e. have worked in national security or US Department of Defense setting or with a government contractor on biosecurity work; this includes helping research or operational experience in bioweapons, pandemic preparedness, biodefense, dual-use synthetic biology, etc) and/or academic experience. Qualified participants may have experience working for government agencies or contractors (e.g. folks from Batelle, Deloitte or SecureBio, or Helena with relevant biosecurity background), or academic exposure (e.g. Johns Hopkins Center for Health Security, MIT Kevin Esvelt lab, etc)
Participants can register only once for the study
Successfully passed background check
Benefits
Earn $40 for every successful participant you refer.
Company
TELUS Digital
TELUS Digital accelerates revenue growth and operational efficiency with AI-fueled technology and expert teams
Funding
Current Stage
Public CompanyTotal Funding
unknown2025-09-02Acquired
2021-02-03IPO
2016-05-05Private Equity
Recent News
2025-11-14
Company data provided by crunchbase